LABIANA HEALTH S.A.EO-10 (8RK) — Capital Reinvestment Ratio
Latest as of December 2024:
0.42x
LABIANA HEALTH S.A.EO-10 (8RK) has a Capital Reinvestment Ratio of 0.42x as of December 2024, meaning it reinvests 0% of its operating cash flow (€7.19 Million) in capital expenditures (€3.05 Million). See 8RK free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.42x
Capex / Operating Cash Flow
Operating Cash Flow
€7.19 Million
EUR
Capital Expenditures
€3.05 Million
EUR
Data as of
Dec 2024
Most recent filing
LABIANA HEALTH S.A.EO-10 Capital Reinvestment Ratio (2021–2024)
This chart tracks LABIANA HEALTH S.A.EO-10's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for LABIANA HEALTH S.A.EO-10 (2021–2024)
Year-by-year Capital Reinvestment Ratio for LABIANA HEALTH S.A.EO-10 from 2021 to 2024. For live market cap and broader valuation context, see 8RK market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | €7.19 Million | €3.05 Million | ▼ -63.7% |
| 2022 | 1.17x | €4.68 Million | €5.45 Million | ▼ -4.5% |
| 2021 | 1.22x | €3.91 Million | €4.77 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow